Prevalence of nonrefractive visual impairment in US adults and associated risk factors, 1999-2002 and 2005-2008
- PMID: 23232894
- PMCID: PMC3810182
- DOI: 10.1001/jama.2012.85685
Prevalence of nonrefractive visual impairment in US adults and associated risk factors, 1999-2002 and 2005-2008
Abstract
Context: Over the past decade, chronic illnesses with ophthalmic sequelae such as diabetes and diabetic retinopathy have increased.
Objectives: To estimate prevalence of nonrefractive visual impairment and to describe its relationship with demographic and systemic risk factors including diagnosed diabetes.
Design, setting, and participants: The National Health and Nutrition Examination Survey (NHANES) examined a representative sample of the US noninstitutionalized population. In 1999-2002 and 2005-2008, 9471 and 10,480 participants aged 20 years or older received questionnaires, laboratory tests, and physical examinations. Visual acuity of less than 20/40 aided by autorefractor was classified as nonrefractive visual impairment.
Main outcome measure: Nonrefractive visual impairment.
Results: Weighted prevalence of nonrefractive visual impairment increased 21% among US adults aged 20 years and older from 1.4% in 1999-2002 to 1.7% in 2005-2008 (P = .03); and increased 40% among non-Hispanic whites aged 20-39 years from 0.5% to 0.7% (P = .008). In multivariable analyses, statistically significant risk factors for nonrefractive visual impairment in 1999-2002 included age (per year odds ratio [OR], 1.07; 95% CI, 1.05-1.09), poverty (OR, 2.18; 95% CI, 1.31-3.64), lack of insurance (OR, 1.85; 95% CI, 1.16-2.95), and diabetes with 10 or more years since diagnosis (OR, 1.93; 95% CI, 1.15-3.25). In 2005-2008, risk factors included age (OR, 1.05; 95% CI, 1.04-1.07), poverty (OR, 2.23; 95% CI, 1.55-3.22), education less than high school (OR, 2.11; 95% CI, 1.54-2.90), and diabetes with 10 or more years since diagnosis (OR, 2.67; 95% CI, 1.64-4.37). Prevalence of diabetes with 10 or more years since diagnosis increased 22% overall from 2.8% to 3.6% (P = .02); and 133% among non-Hispanic whites aged 20-39 years from 0.3% to 0.7% (P < .001).
Conclusion: Prevalence of nonrefractive visual impairment was significantly higher in 2005-2008 than in 1999-2002 and may be attributable, in part, to higher prevalence of diabetes, an associated risk factor that increased in prevalence during this time period.
Comment in
-
Diabetes and nonrefractive visual impairment: the young have it.JAMA. 2012 Dec 12;308(22):2403-4. doi: 10.1001/jama.2012.114286. JAMA. 2012. PMID: 23232897 No abstract available.
-
Is the prevalence of visual impairment rising or falling in the people with diabetes mellitus? It depends on who you study.JAMA Ophthalmol. 2013 Jul;131(7):948-50. doi: 10.1001/jamaophthalmol.2013.4023. JAMA Ophthalmol. 2013. PMID: 24015401 No abstract available.
References
-
- Vitale S, Cotch MF, Sperduto RD. Prevalence of visual impairment in the United States. JAMA. 2006;295(18):2158–2163. - PubMed
-
- Congdon N, O’Colmain B, Klaver CC, et al. Eye Diseases Prevalence Research Group Causes and prevalence of visual impairment among adults in the United States. Arch Ophthalmol. 2004;122(4):477–485. - PubMed
-
- Zambelli-Weiner A, Crews JE, Friedman DS. Disparities in Adult Vision Health in the United States [published online ahead of print May 23, 2012] Am J Ophthalmol. DOI:10.1016/j.ajo.2012.03.018. - PubMed
-
- Zhang X, Gregg EW, Cheng YJ, et al. Diabetes mellitus and visual impairment: national health and nutrition examination survey, 1999-2004. Arch Ophthalmol. 2008;126(10):1421–1427. - PubMed
-
- Kempen JH, O’Colmain BJ, Leske MC, et al. Eye Diseases Prevalence Research Group The prevalence of diabetic retinopathy among adults in the United States. Arch Ophthalmol. 2004;122(4):552–563. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
